Knock E

St. Vincent's Hospital Alcohol and Drug Service, Sydney, Australia.

5 papers

ArticlePsilocybin

A qualitative analysis of participant expectations and experiences of psilocybin-assisted psychotherapy for methamphetamine use disorder.

Brett J, Lea T, Knock E +4

Europe PMC2025
ArticlePsilocybin

Psilocybin-assisted psychotherapy for methamphetamine use disorder: A pilot open-label safety and feasibility study.

Knock E, Siefried KJ, Bedi G +6

Europe PMC2025
ArticleKetamine

Protocol of an open-label safety and feasibility pilot study of ketamine-assisted psychothera<u>p</u>y for methamphetamine use disorder (the KAPPA trial).

Fletcher K, Ezard N, Siefried KJ +11

Europe PMC2025
ArticlePsilocybin

Psilocybin-assisted psychotherapy for methamphetamine dependence: a case report involving daily methamphetamine use.

Brett J, Knock E, Watson K +3

Europe PMC2024
ArticlePsilocybin

Exploring psilocybin-assisted psychotherapy in the treatment of methamphetamine use disorder.

Brett J, Knock E, Korthuis PT +5

Europe PMC2023